LOS ANGELES, CA / ACCESS Newswire / February 1, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a ...

Roche Holding AG delivered a strong set of 2024 earnings. Guidance for 2025 suggests this will be a transitional year ahead, ...

Q1 2025 Earnings Call Transcript January 29, 2025 Operator: Good day and thank you for standing by. Welcome to the Ashland ...

I’m not going to report record revenue, but it was nonetheless a robust year," CEO Bernard Arnault said during the earnings ...

Sales of $405 million, down 14 percent from the prior-year quarterPreviously announced carboxymethylcellulose (CMC), methylcellulose (MC) and ...

Jim Cramer in a latest program on CNBC reminded viewers about the Trump playbook in the story market and said that he never ...

Texas Instruments falls after the chip maker’s first-quarter earnings forecast misses estimates, and Boeing declines after ...

Analysts were bullish on Netflix stock ahead of its earnings beat, but what is Wall Street saying now? We take a closer look.

FB Financial Corporation's recent fourth-quarter 2024 earnings conference call offered a glimpse into the company's continued success, driven by its solid operating foundation and unique local market ...

In a recent conference call, Fifth Third Bancorp delivered a stellar performance in the fourth quarter of 2024, exceeding expectations across various key metrics. The bank's Chairman, CEO, and ...

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $52.5 to $120.0 for Novo Nordisk over the last 3 months.

The shares of Danish weight-loss drug maker Novo Nordisk (NVO) are retreating 5% today, while Eli Lilly (LLY), which makes a similar treatment, is giving back 2.5%.